Skip Ribbon Commands
Skip to main content
Webcasts and Presentations
Click here for webcast
Q3 2016 West Pharmaceutical Services Earnings Conference Call
October 27, 2016 9:00 a.m. ET
NYSE: WSTSee Quotes >>
LAST: 71.68 4:02 p.m. ET
Change: -0.81    -1.12%
See Chart >>

Shareholders may receive, free of charge, a hard copy of West Pharmaceutical Service's complete audited financial statements by sending a written request to West Pharmaceutical Services, Inc. Attn: Company's Secretary, 530 Herman O. West Drive, Exton, PA 19341.

Latest Releases
10/17/2016 7:01:03 AM
West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices
10/13/2016 7:01:00 AM
West to Host Third Quarter 2016 Conference Call
9/26/2016 8:00:48 AM
West Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain
Corporate Overview

West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2015 sales of $1.4 billion reflect the daily use of approximately 110 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.

Investor Contacts

Quintin Lai Ph.D.
Vice President, Corporate Development, Strategy and Investor Relations